StemoniX Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
M&A
- Investors
-
1
StemoniX General Information
Description
Developer of a human-induced cardiac screening platform designed to improve and accelerate the process of neurotoxicity research and drug screening. The company's platform creates new cell-based disease models, and operationalizes custom human induced pluripotent stem cells (iPSC) disease models at a large scale for high-throughput screening, enabling scientists to conduct research with improved outcomes in a simplified workflow economically.
Contact Information
Website
www.stemonix.comCorporate Office
- 13300 67th Avenue North
- Maple Grove, MN 55311
- United States
Corporate Office
- 13300 67th Avenue North
- Maple Grove, MN 55311
- United States
StemoniX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Merger/Acquisition | 24-Oct-2023 | Completed | Generating Revenue | |||
| 18. Later Stage VC (Series B) | 01-Dec-2022 | Completed | Generating Revenue | |||
| 17. Later Stage VC | 01-Jun-2021 | Completed | Generating Revenue | |||
| 16. Merger/Acquisition | 30-Mar-2021 | Completed | Generating Revenue | |||
| 15. Later Stage VC | 01-Jan-2021 | Completed | Generating Revenue | |||
| 14. Debt - PPP | 10-Apr-2020 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series B) | 23-Oct-2019 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 11-Oct-2019 | Completed | Generating Revenue | |||
| 11. Early Stage VC | 06-Sep-2018 | $4.94M | $13.3M | Completed | Generating Revenue | |
| 10. Early Stage VC (Series A) | 10-Mar-2017 | $2.41M | $8.41M | Completed | Generating Revenue |
StemoniX Comparisons
Industry
Financing
Details
StemoniX Competitors (35)
One of StemoniX’s 35 competitors is Cellaion, a Formerly VC-backed company based in Mont-Saint-Guibert, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellaion | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| Sernova Biotherapeutics | Corporation | Mississauga, Canada | ||||
| Treefrog Therapeutics | Venture Capital-Backed | Pessac, France | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ | ||||
| iXCells Biotechnologies | Private Equity-Backed | San Diego, CA |
StemoniX Patents
StemoniX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020216980-A1 | Method of using human spheroids for drug discovery | Inactive | 02-Feb-2019 | ||
| JP-2023090807-A | Method of using human spheroids for drug discovery | Pending | 02-Feb-2019 | ||
| WO-2020160470-A1 | Method of using human spheroids for drug discovery | Inactive | 02-Feb-2019 | ||
| US-20190085296-A1 | Method of expansion of human pancreas progenitor cells from stem cells using feeder-conditioned media | Inactive | 20-Sep-2017 | ||
| EP-3679124-A1 | Efficient differentiation of human stem cells to definitive endoderm | Inactive | 07-Sep-2017 | C12N5/0678 |
StemoniX Signals
StemoniX Former Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 701 Fund | Angel Group | Minority | ||
| Alumni Ventures | Venture Capital | Minority | ||
| Brightstone Venture Capital | Venture Capital | Minority | ||
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Catalytic Impact Foundation | Not-For-Profit Venture Capital | Minority |
StemoniX Investments (1)
StemoniX’s most recent deal was a Joint Venture with Joint Venture (StemoniX and Atomwise). The deal was made on 03-Dec-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (StemoniX and Atomwise) | 03-Dec-2019 | Joint Venture | Drug Discovery |
StemoniX Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| StemoniX (MicroBrain Technology) | Maple Grove, MN |
StemoniX FAQs
-
When was StemoniX founded?
StemoniX was founded in 2014.
-
Where is StemoniX headquartered?
StemoniX is headquartered in Maple Grove, MN.
-
What is the size of StemoniX?
StemoniX has 14 total employees.
-
What industry is StemoniX in?
StemoniX’s primary industry is Biotechnology.
-
Is StemoniX a private or public company?
StemoniX is a Private company.
-
What is StemoniX’s current revenue?
The current revenue for StemoniX is .
-
How much funding has StemoniX raised over time?
StemoniX has raised $24.1M.
-
Who are StemoniX’s investors?
701 Fund, Alumni Ventures, Brightstone Venture Capital, CONNECT (San Diego), and Catalytic Impact Foundation are 5 of 25 investors who have invested in StemoniX.
-
Who are StemoniX’s competitors?
Cellaion, Sernova Biotherapeutics, Treefrog Therapeutics, Lisata Therapeutics, and iXCells Biotechnologies are some of the 35 competitors of StemoniX.
-
When was StemoniX acquired?
StemoniX was acquired on 24-Oct-2023.
-
Who acquired StemoniX?
StemoniX was acquired by 28bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process